Nuvilex Advances Release of Citroxin(TM) Antiviral Surface Cleaner to Help Combat... ( CHERRY HILL N.J. April 29 /-Nuvilex I...)

Nuvilex Advances Release of Citroxin(TM) Antiviral Surface Cleaner to Help Combat Swine Flu

Date:4/29/2009

CHERRY HILL, N.J., April 29 /PRNewswire-FirstCall/ --Nuvilex, Inc. (OTC Bulletin Board: NVLX), an emerging healthcare consumer products company, today announced that it will advance the release of Citroxin to domestic and international health agencies including hospitals, clinics, and medical offices as well as other at risk institutions and companies, such as schools and airlines. Nuvilex has proof of Citroxin's effectiveness in eliminating swine influenza virus (SIV; H1N1 subtype) and avian influenza virus (AIV; H9N9 subtype) on surface areas but has not yet submitted Citroxin for EPA approval as an antiviral agent. Citroxin samples will be provided at no cost and the Company will provide technical assistance. Citroxin is being released early as the current Swine Flu outbreak requires the best products be deployed to combat the growing epidemic.

Independent laboratory testing of Citroxin showed a 100% kill rate for the "big six" bacterial health threats, including E. coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, Streptococcus, and Black Mold. Citroxin is an EPA registered germicidal composition (EPA registration number 82723-1) and is patented in the US and world wide (US 7,439,218 and WIPO 2007/038265 A3).

Interested parties should contact A. Peter Morello III, Ph.D., Director of Research at Nuvilex via a specially set up email address: citroxin@nuvilex.com for product information and specifications as well as to request a sample.

"Given the seriousness of the threat of the spread of swine flu, we believe it is our duty to push hard to make Citroxin available as soon as possible," said Martin E. Schmieg, Chairman and CEO of Nuvilex, Inc. "Much of the innovation in science and technology for combating big problems comes from small companies such
'/>"/>

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. Nuvilex, Inc. Announces Investor Conference Call and Open House
2. Nuvilex, Inc.s Marketing Partner, CK41 to Launch purEffect(TM) in May
3. Nuvilex, Inc. Announces New Pricing for Cinnergen and Launch of dLife Advertising and Promotion Campaign
4. Nuvilex Provides Conference Call Replay Information
5. Nuvilex, Inc. Launches Spring Break Initiatives Designed to Raise Visibility Among Key Demographic Group
6. Nuvilex Infinitink Tattoo Ink Featured on PBS alt.news 26:46 TV Program
7. eFoodSafety.com, Inc. Changes Name to Nuvilex, Inc., Reflecting New Strategic Direction of Company
8. New advances in cancer research to be highlighted at University of Leicester
9. Male Cosmetic Surgery Slows Down While Female Cosmetic Surgery Advances
10. Survey Results: Health Care Technology Advances as Physician Frustration Grows
11. Stemedica Advances its Certification to Become a Licensed Manufacturer of Adult Stem Cells for U.S. Based Clinical Trials

Post Your Comments:

Nuvilex Advances Release of Citroxin(TM) Antiviral Surface Cleaner to Help Combat...( CHERRY HILL N.J. April 29 /-Nuvilex I...),Health